CRO Sygnature Discovery has announced the appointment of Susanne Back as Head of In Vivo Pharmacology. Back has 20 years of in vivo pharmacology experience across academia and industry, including...
Takeda has posted phase 3 data on an autoimmune asset it acquired for $4 billion, laying down a marker ahead of a fight for market share...
The China National Intellectual Property Administration (CNIPA) has granted a new patent for Radspherin, a radiopharmaceutical treating micrometastases in cancer patients. Radspherin, developed by biotechnology company...
WASHINGTON — In the past three years, Robert F. Kennedy Jr. has had a dramatic ascent, rocketing from the contrarian fringe to the center of the American health...
The leading medical school accreditation body in the U.S. has removed language from its standards that had required schools it validates to teach about health inequities. ...
Decades after the Vietnam War, hematologist-oncologist Mikkael Sekeres began seeing veterans in his clinic with myelodysplastic syndromes, a group of blood cancers known as MDS. Many...
In February, the U.S. DOGE Service released a gigantic dataset showing Medicaid provider spending from every month from 2018 to 2024. Social media buzzed with eye-popping...
After decades of research, there is little doubt that nutrition plays a critical role in promoting health across the lifespan. This is especially true among vulnerable...
Imagine seeing a patient who drinks excessively, eats only foods high in saturated and trans fats, never exercises, and ignores prescribed medications — yet constantly complains...
Andres Vidal-Gadea’s neuroscience research was going well. A molecular neuroethologist at Illinois State University, he studies the function of genes, sussing out ways to stop the...